Results 111 to 120 of about 29,066 (192)

Phenotypic Clustering of Idiopathic Pulmonary Arterial Hypertension: Insights Into Pulmonary Vascular and Cardiometabolic Co-Morbidity Trajectories. [PDF]

Pulm Circ
Kaymaz C, Kultursay B, Tokgoz HC, Tanyeri S, Bulus C, Keskin B, Cagliyan CE, Kibar M, Erdem C, Vezir A, Akkus I, Bulut M, Hakgor A, Tanboga IH, Ozdemir N.   +14 more
europepmc   +1 more source

Divergent Inflammatory and Bioenergetic Metabolomic Signatures Distinguish Methamphetamine-Associated From Idiopathic Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Robertson HK, Yuguchi E, Gurholt I, Nichols WC, Kim NH, Fernandes T, Malhotra A, Alotaibi M.   +7 more
europepmc   +1 more source

Comprehensive analysis of m⁶A methylomes in idiopathic pulmonary arterial hypertension. [PDF]

Epigenetics, 2023
Huang T, Zeng Y, Yang Y, Fan H, Deng Y, Chen W, Liu J, Yang F, Li W, Xiao Y.   +9 more
europepmc   +1 more source

Coronary pathophysiology in idiopathic pulmonary arterial hypertension. [PDF]

JCI Insight
Boland E, Freeman MG, Corcoran DS, Ford TJ, Hennigan B, Collison D, Llucià-Valldeperas A, de Man FS, Balachandran KP, Johnson M, Church C, Berry C.   +11 more
europepmc   +1 more source

Lifesaving Compassionate-Use of Sotatercept in a 12-Year-old With Idiopathic Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Pelczar-Płachta W, Surmacz R, Bobkowski W.   +2 more
europepmc   +1 more source

Comparison of Functional and Hemodynamic Parameters Between Methamphetamine-Associated and Idiopathic Pulmonary Arterial Hypertension: Systematic Review and Meta-Analysis. [PDF]

Healthcare (Basel)
Papaioannou F, Karagiannis T, Boutou A, Georgopoulou A, Kaprinis S, Pitsiou G.   +5 more
europepmc   +1 more source

Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort. [PDF]

Pharmaceuticals (Basel)
Filippatos C, Boutsikos I, Tepetes NI, Xanthopoulos A, Duque ER, Asleh R, Giannakoulas G, Briasoulis A.   +7 more
europepmc   +1 more source

Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension. [PDF]

NPJ Cardiovasc Health
Delgado-SanMartin JA, Keles M, Errington N, Schuetz N, Johnson A, Gupta V, Hershman S, Toshner M, Wilkins MR, Kiely DG, Thompson R, Ashley E, Wang D, Lawrie A.   +13 more
europepmc   +1 more source

Initial triple combination therapy including sotatercept in a patient with severe idiopathic pulmonary arterial hypertension: a case report. [PDF]

ERJ Open Res
Park DH, Kamp JC, Seeliger B, Hoeper MM, Olsson KM.   +4 more
europepmc   +1 more source

Serum Proteomic Profiling Uncovers LGALS3BP as a Potential Biomarker for Idiopathic Pulmonary Arterial Hypertension. [PDF]

Clin Respir J
Li M, Jin Q, Pan W, Tian D, Wang P, Chen D, Zhang Y, Chen S, Zhou D, Guan L, Ge J.   +10 more
europepmc   +1 more source